Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Search Results for: Generic stromectol Wester%6

Three cybersecurity precautions for compliance teams everywhere

[…] the device or funnel the user to a different website that scoops up information that would give the hacker access to the user’s credentials.  We’ve all seen generic phishing attempts, but a more dangerous variation known as “spear-phishing” explicitly targets specific individuals. Often, targets are senior executives with discretionary power. In 2016, a Belgian […]

Read More »

What the heck is risk-based training?

[…] audit personnel should clearly receive in-depth training on corruption risks relevant to their organization and procedures for testing anti-corruption compliance controls.  It is highly unlikely that a generic one-hour corporate training session will be sufficient to train an Internal Audit team, particularly if they work for a U.S. issuer with Books and Records and […]

Read More »

Yikes: Companies still don’t grasp their true corruption risks

[…] risk assessments and 89 percent regularly monitoring and updating their ABC controls. Part of the problem is that risk assessments are undermined by being too high-level or generic. A detailed risk assessment will focus on the granular details of corruption risks. Key areas include selling through intermediaries and operating in sectors and countries where […]

Read More »

The perils of measuring compliance program ‘effectiveness’

[…] percent). Yet, ratings fail to clarify whether senior leaders talk about the E&C plan in relation to the larger business plan and related business goals in a generic or specific way. They also say nothing about how the E&C plan fares with respect to day-to-day business practices, in particular in situations in which employees […]

Read More »

Six common pitfalls and blind spots to avoid when creating compliant organizations

[…] allows companies to tie together different data points or data sets as well to map flashpoints in their organization where they need to dedicate more resources. 6. Generic ABAC training Training that is general and not tailored to specific job functions by definition has limited applicability for different parts of the business where risks […]

Read More »

Martin Kenney: Why is the pressure on compliance professionals so intense?

[…] there is also the possibility that those conducting due diligence checks would simply “comply” and no more, knowing that they had covered their backs by ticking the generic boxes. There may well be software out there capable of running searches and ticking the boxes alluded to. But at this time, computers cannot develop a […]

Read More »

Richard Bistrong: Put your faith in the brand, not the bribe

[…] contract. Yet the formula of spray I was selling was world class, with an exemplary health and safety record. I wasn’t selling a commodity item or a generic brand. My product stood out for all the right reasons. But that’s not what I thought about during the sales process. What I thought about instead […]

Read More »

Teva Pharmaceuticals resolves bribery case with Israel authorities

[…] filed. In Teva’s U.S. FCPA enforcement action, the company paid total penalties to the DOJ and SEC of $519 million. Teva is the world’s biggest manufacturer of generic drugs. It committed the FCPA offenses in Ukraine, Mexico, and Russia. According to the U.S. enforcement action, Teva did business in Russia with a repackaging company […]

Read More »

Kmart whistleblower awarded $9 million for prescription drug overcharges

[…] intervene, whistleblowers can litigate on their own to recover funds for the government. According to Garbe’s complaint, in one case Kmart sold a 30-day supply of a generic prescription drug for $5 to customers of its discount program but filed for reimbursement from the government for $152 for the same drug for Medicare customers. […]

Read More »